Overview
Lipocalin-2 (also known as NGAL — neutrophil gelatinase-associated lipocalin, or siderocalin) is a 25 kDa secreted protein produced by activated neutrophils, epithelial cells, and other innate immune cells. Its primary antimicrobial function is to sequester bacterial siderophores — iron-scavenging molecules secreted by pathogenic bacteria — preventing pathogen iron acquisition.
Lipocalin-2 is one of the most potent anti-bacterial defenses in the nutritional immunity arsenal. Unlike transferrin (which sequesters circulating Fe³⁺), lipocalin-2 directly targets the bacterial iron-uptake machinery.
Mechanism
Siderophore binding: Lipocalin-2 contains a hydrophobic binding pocket that binds iron-loaded siderophores with nanomolar affinity, particularly enterobactin (from Gram-negative bacteria like E. coli) and other catecholate siderophores. Once liganded, the siderophore-iron complex is sequestered and rendered unavailable for bacterial uptake.
Bacterial counter-mechanisms: Pathogens evolve multi-dentate "stealth" siderophores that have lower affinity for lipocalin-2. For example:
- E. coli K-12 produces enterobactin (recognized by lipocalin-2)
- E. coli strains pathogenic in urinary tract and bloodstream produce salmochelin (a glucosylated enterobactin derivative with reduced lipocalin-2 binding)
- Salmonella produces salicylate-based siderophores with altered lipocalin-2 affinity
Expression control: Lipocalin-2 is an acute-phase reactant — expression is induced by TNF-α, IL-6, LPS, and bacterial lipopolysaccharides. In the gut, both intestinal epithelial cells and infiltrating neutrophils upregulate lipocalin-2 in response to pathogenic Gram-negative bacteria.
Role in Disease
Elevated fecal lipocalin-2 is a key biomarker of intestinal inflammation and pathogenic bacterial dominance:
- Crohns disease: Markedly elevated in active inflammation; indicates AIEC-dominant signatures and nutritional immunity activation
- Colorectal cancer: Elevated in dysplastic lesions and tumor microenvironment; associated with Gram-negative pathobiont dominance
- Obesity: Elevated in low-grade endotoxemia; reflects barrier breach and Gram-negative bacterial translocation
- Ulcerative colitis: Surrogate marker of mucosal neutrophil infiltration
- Bacterial infections generally: Urinary tract infection (elevated urinary lipocalin-2), pneumonia, sepsis
Interpretation nuance: High lipocalin-2 indicates active immune engagement with iron-dependent Gram-negatives, not a failure of defense. It is a sign that the host is winning the nutritional immunity battle—if lipocalin-2 were absent, the pathogens would already be iron-replete and proliferating unchecked.
Metal Connections
Lipocalin-2 is a master regulator of iron ecology in the gut:
- Siderophore sequestration: Traps iron-loaded enterobactin, preventing pathogenic E. coli from importing it via outer-membrane receptors (FepA, FecA)
- Ecological reshaping: High lipocalin-2 → low bioavailable iron → selects against siderophore-dependent Gram-negatives → favors anaerobes (Bacteroides, Lachnospiraceae) that use alternative iron uptake (e.g., heme-iron via B. fragilis IrgA)
- Interkingdom spillover: Some fungi (C. albicans) also produce siderophores; lipocalin-2 also targets fungal iron uptake
Connections
Related proteins:
- Transferrin — serum iron sequestration; complementary mechanism to lipocalin-2
- Lactoferrin — mucosal siderophore defense; overlapping mechanism with lipocalin-2 but higher affinity for Fe³⁺
- Hepcidin — systemic iron regulation; often elevated in parallel with lipocalin-2 during infection
Related concepts:
- Siderophore — the substrate for lipocalin-2 binding
- Nutritional immunity — lipocalin-2 as a key defense component
- Iron ecology — how lipocalin-2 shapes bacterial community structure
- Candida albicans — fungal pathogen also affected by siderophore sequestration
Disease pages:
- Crohns disease, colorectal cancer, obesity, ulcerative colitis — conditions with elevated lipocalin-2
Metal entities:
- Iron — the target of the siderophore-lipocalin-2 battle